Skip to main content

Welkom bij Scalda & Bohn Stafleu van Loghum

Scalda heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen.Je kunt de producten hieronder links aanschaffen en rechts inloggen.

Registreer

Schaf de BSL Academy aan: 

BSL Academy mbo AG

Eenmaal aangeschaft kun je thuis, of waar ook ter wereld toegang krijgen tot Mijn BSL.

Heb je een vraag, neem dan contact op met Jan van der Velden.

Login

Als u al geregistreerd bent, hoeft u alleen maar in te loggen om onbeperkt toegang te krijgen tot Mijn BSL.

Top
Gepubliceerd in:

29-10-2024

Quality of life of inflammatory bowel diseases patients in france with EQ-5D-5 L: the QALY-MICI study

Auteurs: H. Sarter, J. Kirschgesner, L. Beaugerie, A. Buisson, C. Gower-Rousseau, Gérard de Pouvourville

Gepubliceerd in: Quality of Life Research | Uitgave 2/2025

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

This study aimed to document utility values and the Visual Analog Scale (VAS) with the 5-level version of the EQ-5D questionnaire in a large sample of patients with inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC).

Methods

QALY-MICI was a cross-sectional survey across three sources in France. Data were collected between 2019 and 2022 for patients 18 and over. The EQ-5D-5 L, the EQ-VAS, the Short Inflammatory Bowel Disease Questionnaire (SIBDQ), the Harvey-Bradshaw Index (HBI) for CD, and the Walmsley Index for UC (SCCAI) were collected.

Results

A total of 2,841 patients aged over 18 were recruited (1785 with CD, 1056 with UC). The mean age was 40.2 (SD 14.3). The time since diagnosis was 6 years and over for 61.9% of patients. The most impacted dimensions were usual activities, anxiety/ depression, and pain/ discomfort. The mean utility value was 0.863 (SD 0.172) versus 0.905 (SD 0.158) in the French population (p = 0.007). The mean VAS value was 68 (SD 19.2) versus 73.4 (SD 22.2) in the general population (p = 0.016). Utility values and VAS were similar for CD and UC and higher for men. There was a strong positive correlation between utility values, the VAS, and the SIBDQ score, and a negative correlation between the HBI and the SCCAI. The SIBDQ score and disease activity were the main predictors of utility and VAS.

Conclusion

The QALY-MICI is, to our knowledge, the first study documenting utility values and VAS using the EQ-5D-5 L questionnaire on a large sample, with a comparison to the general population.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
3.
go back to reference Benedini V., Caporaso N., Corazza GR., Rossi Z., Fornaciari G., Cottone M., Frosini G., Caruggi M., Ottolini C., Colombo G.L.Burden of Crohn’s disease: economics and quality of life aspects in Italy. Clinicoecon Outcomes Res. 2012;4:209-18. doi: 10.2147/CEOR.S31114. Benedini V., Caporaso N., Corazza GR., Rossi Z., Fornaciari G., Cottone M., Frosini G., Caruggi M., Ottolini C., Colombo G.L.Burden of Crohn’s disease: economics and quality of life aspects in Italy. Clinicoecon Outcomes Res. 2012;4:209-18. doi: 10.2147/CEOR.S31114.
4.
go back to reference Gibson, P. R., Vaizey, C., Black, C. M., Nicholls, R., Weston, A. R., Bampton, P., Sparrow, M., Lawrance, I. C., Selby, W. S., Andrews, J. M., Walsh, A. J., Hetzel, D. J., Macrae, F. A., Moore, G. T., Weltman, M. D., Leong, R. W., & Fan, T. (2014). Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: A cross-sectional, observational study. J Crohns Colitis, 8(7), 598–606. https://doi.org/10.1016/j.crohns.2013.11.017CrossRefPubMed Gibson, P. R., Vaizey, C., Black, C. M., Nicholls, R., Weston, A. R., Bampton, P., Sparrow, M., Lawrance, I. C., Selby, W. S., Andrews, J. M., Walsh, A. J., Hetzel, D. J., Macrae, F. A., Moore, G. T., Weltman, M. D., Leong, R. W., & Fan, T. (2014). Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: A cross-sectional, observational study. J Crohns Colitis, 8(7), 598–606. https://​doi.​org/​10.​1016/​j.​crohns.​2013.​11.​017CrossRefPubMed
7.
go back to reference Van Assche, G., Peyrin-Biroulet, L., Sturm, A., Gisbert, J. P., Gaya, D. R., Bokemeyer, B., Mantzaris, G. J., Armuzzi, A., Sebastian, S., Lara, N., Lynam, M., Rojas-Farreras, S., Fan, T., Ding, Q., Black, C. M., & Kachroo, S. (2016). Burden of disease and patient-reported outcomes in patients with moderate to severe ulcerative colitis in the last 12 months - multicenter European cohort study. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 48(6), 592–600. https://doi.org/10.1016/j.dld.2016.01.011CrossRefPubMed Van Assche, G., Peyrin-Biroulet, L., Sturm, A., Gisbert, J. P., Gaya, D. R., Bokemeyer, B., Mantzaris, G. J., Armuzzi, A., Sebastian, S., Lara, N., Lynam, M., Rojas-Farreras, S., Fan, T., Ding, Q., Black, C. M., & Kachroo, S. (2016). Burden of disease and patient-reported outcomes in patients with moderate to severe ulcerative colitis in the last 12 months - multicenter European cohort study. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 48(6), 592–600. https://​doi.​org/​10.​1016/​j.​dld.​2016.​01.​011CrossRefPubMed
9.
go back to reference Vaizey, C. J., Gibson, P. R., Black, C. M., Nicholls, R. J., Weston, A. R., Gaya, D. R., Sebastian, S., Shaw, I., Lewis, S., Bloom, S., Gordon, J. N., Beale, A., Arnott, I., Campbell, S., & Fan, T. (2014). Disease status, patient quality of life and healthcare resource use for ulcerative colitis in the UK: An observational study. Frontline Gastroenterol, 5(3), 183–189. https://doi.org/10.1136/flgastro-2013-100409Epub 2014 Jan 24.CrossRefPubMedCentralPubMed Vaizey, C. J., Gibson, P. R., Black, C. M., Nicholls, R. J., Weston, A. R., Gaya, D. R., Sebastian, S., Shaw, I., Lewis, S., Bloom, S., Gordon, J. N., Beale, A., Arnott, I., Campbell, S., & Fan, T. (2014). Disease status, patient quality of life and healthcare resource use for ulcerative colitis in the UK: An observational study. Frontline Gastroenterol, 5(3), 183–189. https://​doi.​org/​10.​1136/​flgastro-2013-100409Epub 2014 Jan 24.CrossRefPubMedCentralPubMed
10.
11.
go back to reference Casellas, F., López Vivancos, J., & MalagelaJR (2003). Previous experience and quality of life in patients with inflammatory bowel disease during relapse. Revista Espanola De Enfermedades Digestivas, 95(7), 476–479. English, Spanish. Casellas, F., López Vivancos, J., & MalagelaJR (2003). Previous experience and quality of life in patients with inflammatory bowel disease during relapse. Revista Espanola De Enfermedades Digestivas, 95(7), 476–479. English, Spanish.
15.
go back to reference Huppertz-Hauss, G., Aas, E., Lie Høivik, M., Langholz, E., Odes, S., Småstuen, M., Stockbrugger, R., Hoff, G., Moum, B., & Bernklev, T. (2016). Comparison of the Multiattribute Utility instruments EQ-5D and SF-6D in a Europe-wide Population-based cohort of patients with inflammatory bowel Disease 10 years after diagnosis. Gastroenterology Research and Practice, 2016, 5023973. https://doi.org/10.1155/2016/5023973Epub 2016 Aug 18.CrossRefPubMedCentralPubMed Huppertz-Hauss, G., Aas, E., Lie Høivik, M., Langholz, E., Odes, S., Småstuen, M., Stockbrugger, R., Hoff, G., Moum, B., & Bernklev, T. (2016). Comparison of the Multiattribute Utility instruments EQ-5D and SF-6D in a Europe-wide Population-based cohort of patients with inflammatory bowel Disease 10 years after diagnosis. Gastroenterology Research and Practice, 2016, 5023973. https://​doi.​org/​10.​1155/​2016/​5023973Epub 2016 Aug 18.CrossRefPubMedCentralPubMed
18.
go back to reference Parra, R. S., Chebli, J. M. F., Amarante, H. M. B. S., Flores, C., Parente, J. M. L., Ramos, O., Fernandes, M., Rocha, J. J. R., Feitosa, M. R., Feres, O., Scotton, A. S., Nones, R. B., Lima, M. M., Zaltman, C., Goncalves, C. D., Guimaraes, I. M., Santana, G. O., Sassaki, L. Y., Hossne, R. S., Bafutto, M., Junior, R. L. K., Faria, M. A. G., Miszputen, S. J., Gomes, T. N. F., Catapani, W. R., Faria, A. A., Souza, S. C. S., Caratin, R. F., Senra, J. T., & Ferrari, M. L. A. (2019). Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil. World Journal of Gastroenterology, 25(38), 5862–5882. https://doi.org/10.3748/wjg.v25.i38.5862CrossRefPubMedCentralPubMed Parra, R. S., Chebli, J. M. F., Amarante, H. M. B. S., Flores, C., Parente, J. M. L., Ramos, O., Fernandes, M., Rocha, J. J. R., Feitosa, M. R., Feres, O., Scotton, A. S., Nones, R. B., Lima, M. M., Zaltman, C., Goncalves, C. D., Guimaraes, I. M., Santana, G. O., Sassaki, L. Y., Hossne, R. S., Bafutto, M., Junior, R. L. K., Faria, M. A. G., Miszputen, S. J., Gomes, T. N. F., Catapani, W. R., Faria, A. A., Souza, S. C. S., Caratin, R. F., Senra, J. T., & Ferrari, M. L. A. (2019). Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil. World Journal of Gastroenterology, 25(38), 5862–5882. https://​doi.​org/​10.​3748/​wjg.​v25.​i38.​5862CrossRefPubMedCentralPubMed
20.
go back to reference Hagelund, L. M., Elkjær Stallknecht, S., & Jensen, H. H. (2020). Quality of life and patient preferences among Danish patients with ulcerative colitis - results from a survey study. Current Medical Research and Opinion, 36(5), 771–779. Epub 2020 Jan 24.CrossRefPubMed Hagelund, L. M., Elkjær Stallknecht, S., & Jensen, H. H. (2020). Quality of life and patient preferences among Danish patients with ulcerative colitis - results from a survey study. Current Medical Research and Opinion, 36(5), 771–779. Epub 2020 Jan 24.CrossRefPubMed
22.
go back to reference Irvine, E. J., Zhou, Q., & Thompson, A. K. (1996). The short inflammatory bowel Disease Questionnaire: A quality of life instrument for community physiciyears managing inflammatory bowel disease. CCRPT investigators. Canadian Crohn’s Relapse Prevention Trial. The American Journal of Gastroenterology, 91, 1571–1578.PubMed Irvine, E. J., Zhou, Q., & Thompson, A. K. (1996). The short inflammatory bowel Disease Questionnaire: A quality of life instrument for community physiciyears managing inflammatory bowel disease. CCRPT investigators. Canadian Crohn’s Relapse Prevention Trial. The American Journal of Gastroenterology, 91, 1571–1578.PubMed
23.
go back to reference Rencz, F., Lakatos, P. L., Gulácsi, L., Brodszky, V., Kürti, Z., Lovas, S., Banai, J., Herszényi, L., Cserni, T., Molnár, T., Péntek, M., & Palatka, K. (2019). Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn’s disease. Quality of Life Research, 28(1), 141–152. https://doi.org/10.1007/s11136-018-2003-4Epub 2018 Sep 17.CrossRefPubMed Rencz, F., Lakatos, P. L., Gulácsi, L., Brodszky, V., Kürti, Z., Lovas, S., Banai, J., Herszényi, L., Cserni, T., Molnár, T., Péntek, M., & Palatka, K. (2019). Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn’s disease. Quality of Life Research, 28(1), 141–152. https://​doi.​org/​10.​1007/​s11136-018-2003-4Epub 2018 Sep 17.CrossRefPubMed
24.
go back to reference Panés, J., Domènech, E., Aguas Peris, M., Nos, P., Riestra, S., Juliá de Páramo, B., Cea-Calvo, L., Romero, C., & Marín-Jiménez, I. (2017). Association between disease activity and quality of life in ulcerative colitis: Results from the CRONICA-UC study. Journal of Gastroenterology and Hepatology, 32(11), 1818–1824. https://doi.org/10.1111/jgh.13795CrossRefPubMed Panés, J., Domènech, E., Aguas Peris, M., Nos, P., Riestra, S., Juliá de Páramo, B., Cea-Calvo, L., Romero, C., & Marín-Jiménez, I. (2017). Association between disease activity and quality of life in ulcerative colitis: Results from the CRONICA-UC study. Journal of Gastroenterology and Hepatology, 32(11), 1818–1824. https://​doi.​org/​10.​1111/​jgh.​13795CrossRefPubMed
26.
go back to reference Wolf, T., Lewis, A., Beaugerie, L., et al. (2023). Risk of colorectal neoplasia according to histologic disease activity in patients with inflammatory bowel disease and colonic post-inflammatory polyps. Alimentary Pharmacology & Therapeutics, 57, 1445–1452. https://doi.org/10.1111/apt.17495CrossRef Wolf, T., Lewis, A., Beaugerie, L., et al. (2023). Risk of colorectal neoplasia according to histologic disease activity in patients with inflammatory bowel disease and colonic post-inflammatory polyps. Alimentary Pharmacology & Therapeutics, 57, 1445–1452. https://​doi.​org/​10.​1111/​apt.​17495CrossRef
29.
go back to reference Turner, D., Ricciuto, A., Lewis, A., D’Amico, F., Dhaliwal, J., Griffiths, A. M., Bettenworth, D., Sandborn, W. J., Sands, B. E., Reinisch, W., Schölmerich, J., Bemelman, W., Danese, S., Mary, J. Y., Rubin, D., Colombel, J. F., Peyrin-Biroulet, L., Dotan, I., Abreu, M. T., Dignass, A., & International Organization for the Study of IBD. (2021). STRIDE-II: An update on the selecting therapeutic targets in inflammatory bowel Disease (STRIDE) Initiative of the International Organization for the study of IBD (IOIBD): Determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology, 160(5), 1570–1583. https://doi.org/10.1053/j.gastro.2020.12.031CrossRefPubMed Turner, D., Ricciuto, A., Lewis, A., D’Amico, F., Dhaliwal, J., Griffiths, A. M., Bettenworth, D., Sandborn, W. J., Sands, B. E., Reinisch, W., Schölmerich, J., Bemelman, W., Danese, S., Mary, J. Y., Rubin, D., Colombel, J. F., Peyrin-Biroulet, L., Dotan, I., Abreu, M. T., Dignass, A., & International Organization for the Study of IBD. (2021). STRIDE-II: An update on the selecting therapeutic targets in inflammatory bowel Disease (STRIDE) Initiative of the International Organization for the study of IBD (IOIBD): Determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology, 160(5), 1570–1583. https://​doi.​org/​10.​1053/​j.​gastro.​2020.​12.​031CrossRefPubMed
Metagegevens
Titel
Quality of life of inflammatory bowel diseases patients in france with EQ-5D-5 L: the QALY-MICI study
Auteurs
H. Sarter
J. Kirschgesner
L. Beaugerie
A. Buisson
C. Gower-Rousseau
Gérard de Pouvourville
Publicatiedatum
29-10-2024
Uitgeverij
Springer New York
Gepubliceerd in
Quality of Life Research / Uitgave 2/2025
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-024-03821-x